Patients with chronic kidney disease (CKD) are at significantly increased risk for serious cardiovascular (CV) events and require a personalized strategy for CV risk management to reduce cardiovascular morbidity and mortality.
In this ReCAP, Dr Rajiv Agarwal of Indiana University, Indianapolis, Indiana, highlights a proactive approach to CV risk management in patients with nondialysis CKD, including measuring albuminuria more frequently, discussing lifestyle modifications with patients, and prescribing cardioprotective therapies that have shown to be effective for reducing CKD progression and/or CV events in patients with CKD.
Dr Agarwal also discusses the ongoing FLOW trial, which will evaluate the effect of semaglutide on kidney outcomes in participants with CKD and type 2 diabetes.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Managing Cardiovascular Risk in Patients With Chronic Kidney Disease - Medscape - Sep 18, 2023.
Comments